Literature DB >> 35584828

Thrombocytopenia: the good, the bad and the ugly.

Iona Ashworth1, Lieze Thielemans2, Timothy Chevassut3.   

Abstract

New thrombocytopenia may be associated with a variety of conditions and diagnosis can be challenging. Presentation can vary from life-threatening bleeding or thrombosis to an incidental finding in an asymptomatic patient. New thrombocytopenia requires urgent investigation. Investigations are mainly guided by findings from the clinical history, physical examination, full blood count and blood film analysis. Aside from the actively bleeding patient, rare but life-threatening causes of thrombocytopenia must be identified early as they require urgent treatment. These include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, suspicion of new acute promyelocytic leukaemia, and vaccine-induced prothrombotic immune thrombocytopenia. Here, we discuss how to approach a patient with new thrombocytopenia, along with key differentials not to be missed. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  bleeding; haematology; platelets; thrombocytopenia; thrombosis

Mesh:

Year:  2022        PMID: 35584828      PMCID: PMC9135082          DOI: 10.7861/clinmed.2022-0146

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  17 in total

Review 1.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

2.  The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.

Authors:  Bruno Girolami; Paolo Prandoni; Piero M Stefani; Cinzia Tanduo; Paola Sabbion; Petra Eichler; Roberto Ramon; Giovannella Baggio; Fabrizio Fabris; Antonio Girolami
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

Review 3.  How I treat thrombocytopenia in pregnancy.

Authors:  Terry Gernsheimer; Andra H James; Roberto Stasi
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

Review 4.  How to approach thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

5.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Authors:  Nadine Martel; James Lee; Philip S Wells
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

6.  Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Authors:  M Levi; C H Toh; J Thachil; H G Watson
Journal:  Br J Haematol       Date:  2009-02-12       Impact factor: 6.998

7.  Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

Authors:  Marie Scully; Beverley J Hunt; Sylvia Benjamin; Ri Liesner; Peter Rose; Flora Peyvandi; Betty Cheung; Samuel J Machin
Journal:  Br J Haematol       Date:  2012-05-25       Impact factor: 6.998

8.  Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Authors:  Jan Menne; Yahsou Delmas; Fadi Fakhouri; Christoph Licht; Åsa Lommelé; Enrico E Minetti; François Provôt; Eric Rondeau; Neil S Sheerin; Jimmy Wang; Laurent E Weekers; Larry A Greenbaum
Journal:  BMC Nephrol       Date:  2019-04-10       Impact factor: 2.388

Review 9.  Vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Frederikus A Klok; Menaka Pai; Menno V Huisman; Michael Makris
Journal:  Lancet Haematol       Date:  2021-11-11       Impact factor: 18.959

10.  Prothrombotic immune thrombocytopenia after COVID-19 vaccination.

Authors:  Andreas Tiede; Ulrich J Sachs; Andreas Czwalinna; Sonja Werwitzke; Rolf Bikker; Joachim K Krauss; Frank Donnerstag; Karin Weißenborn; Günter Höglinger; Benjamin Maasoumy; Heiner Wedemeyer; Arnold Ganser
Journal:  Blood       Date:  2021-07-29       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.